Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists
Read Article
News
2024
2023
Archive
Search news articles
November 8, 2021
Akouos Appoints Stacy Price as Chief Technical Officer
November 4, 2021
NodThera Announces Progress of NT-0796, a Novel NLRP3 Inflammasome Inhibitor, into a Phase 1 First-in-Human Study
November 2, 2021
Cabaletta Bio Reports Clinical Data from the Third Dose Cohort in DesCAARTes™ Trial in Patients with mPV
October 29, 2021
Entrada Therapeutics Announces Pricing of Upsized Initial Public Offering
October 28, 2021
Ensoma Strengthens Scientific Advisory Board with Leaders in Oncology and Primary Immune Deficiencies
October 27, 2021
Pear Therapeutics and Thimble Point Aquisition Corp. Announce Effectiveness of S-4 Registration Statement and Set November 23, 2021 for Thimble Point Special Stockholder Meeting to Vote on Proposed Business Combination
October 21, 2021
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
October 21, 2021
Artiva Biotherapeutics to Present Preclinical Data for AB-201, a HER2-Targeting CAR-NK Cell Therapy, at SITC 36th Annual Meeting
October 21, 2021
Homology Medicines Announces Presentations Across Gene Therapy and Gene Editing Programs, including GTx-mAb, at European Society of Gene & Cell Therapy Meeting
October 20, 2021
Homology Medicines Announces Presentation of Data Supporting Clinical Programs in MPS II and PKU, including Nonclinical and Patient-Focused Research, at American Society of Human Genetics Meeting
« Previous Page
1
…
32
33
34
35
36
…
118
Next Page »